بدائل البحث:
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث), we decrease (توسيع البحث)
late decrease » rate decreased (توسيع البحث), larger decrease (توسيع البحث), water decreases (توسيع البحث)
i large » ai large (توسيع البحث), _ large (توسيع البحث), a large (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث), we decrease (توسيع البحث)
late decrease » rate decreased (توسيع البحث), larger decrease (توسيع البحث), water decreases (توسيع البحث)
i large » ai large (توسيع البحث), _ large (توسيع البحث), a large (توسيع البحث)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
ECoG timescales decrease during spatial attention.
منشور في 2025"…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …"
-
8
-
9
-
10
Table of step height.
منشور في 2024"…Finally, by making corresponding test blocks, it was found that the peak value of forward resistance when the 10.5°test block crossed the steps of 1mm, 2mm and 3mm height decreased by 19.8%, 25.0% and 13.9% respectively, and the mean value decreased by 30.8%, 27.2% and 24.1% respectively, which was close to the simulation results, and verified the accuracy of the finite element analysis results.…"
-
11
The well wall step.
منشور في 2024"…Finally, by making corresponding test blocks, it was found that the peak value of forward resistance when the 10.5°test block crossed the steps of 1mm, 2mm and 3mm height decreased by 19.8%, 25.0% and 13.9% respectively, and the mean value decreased by 30.8%, 27.2% and 24.1% respectively, which was close to the simulation results, and verified the accuracy of the finite element analysis results.…"
-
12
-
13
-
14
-
15
-
16
-
17
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
منشور في 2025الموضوعات: -
18
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
منشور في 2025الموضوعات: -
19
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
منشور في 2025الموضوعات: -
20